{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:11:51Z","timestamp":1747368711674,"version":"3.40.5"},"reference-count":12,"publisher":"American Academy of Insurance Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Insur Med"],"published-print":{"date-parts":[[2023]]},"abstract":"<jats:p>Pituitary adenomas were recently reclassified as \u201cneuroendocrine tumors,\u201d and are now considered to be cancers. The evolution and justification for this change are described.<\/jats:p>\n        <jats:p>Critical illness policies, which currently provide coverage of pituitary adenomas under the \u201cBenign Brain Tumor\u201d provision must now be modified to reflect this new taxonomy. This change also prompts questions about the use of the words \u2018benign\u2019 and \u2018tumor\u2019 in critical illness policies.<\/jats:p>","DOI":"10.17849\/insm-50-2-154-156.1","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T17:07:37Z","timestamp":1708016857000},"page":"154-156","source":"Crossref","is-referenced-by-count":2,"title":["From Benign to Malignant: The Arrival of Pituitary Neuroendocrine Tumors (PitNETs)"],"prefix":"10.17849","volume":"50","author":[{"given":"Timothy","family":"Meagher","sequence":"first","affiliation":[{"name":"Address of Correspondent: Munich Re, 1000 Rue de la Gaucheti\u00e8re Ouest, 20e \u00e9tage, Montr\u00e9al Qu\u00e9bec, H3B 4W5; 514-392-5069; tmeagher@munichre.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7324","reference":[{"key":"i0743-6661-50-2-154-ref01","series-title":"Endocrine-Related Cancer","first-page":"C5","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","unstructured":"Asa\n              SL,\n            \n            \n              Casar-Borota\n              O,\n            \n            \n              Chanson\n              P,\n            \n            et al.\n          \n          From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.\nEndocrine-Related Cancer.\n2017;\n24:\nC5-\nC8.\nhttps:\/\/doi.org\/10.1530\/ERC-17-0004"},{"key":"i0743-6661-50-2-154-ref02","series-title":"Mod Pathol","first-page":"1770","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","unstructured":"Rindi\n              G,\n            \n            \n              Klimstra\n              DS,\n            \n            \n              Abedi-Ardekani\n              B,\n            \n            et al.\n          \n          A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.\nMod Pathol.\n2018;\n31:\n1770-\n1786.\ndoi: 10.1038\/s41379-018-0110-y.\nEpub 2018 Aug 23. PMID: 30140036; PMCID: PMC6265262."},{"key":"i0743-6661-50-2-154-ref03","series-title":"Cancers (Basel","first-page":"514","article-title":"How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020","volume":"12","author":"Trouillas","year":"2020","unstructured":"Trouillas\n              J,\n            \n            \n              Jaffrain-Rea\n              ML,\n            \n            \n              Vasiljevic\n              A,\n            \n            et al.\n          \n          How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020.\nCancers (Basel).\n2020;\n12:\n514.\ndoi: 10.3390\/cancers12020514.\nPMID: 32098443; PMCID: PMC7072139."},{"key":"i0743-6661-50-2-154-ref04","series-title":"Pituitary","first-page":"569","article-title":"A tale of pituitary adenomas: to NET or not to NET","volume":"22","author":"Ho","year":"2019","unstructured":"Ho\n              KKY,\n            \n            \n              Fleseriu\n              M,\n            \n            \n              Wass\n              J,\n            \n            et al.\n          \n          A tale of pituitary adenomas: to NET or not to NET.\nPituitary.\n2019;\n22:\n569-\n573.\nhttps:\/\/doi.org\/10.1007\/s11102-019-00988-2"},{"key":"i0743-6661-50-2-154-ref05","series-title":"Curr Med Sci","first-page":"1111","article-title":"Overview of the 2022 WHO Classification of Pituitary Adenomas\/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives","volume":"42","author":"Wan","year":"2022","unstructured":"Wan\n              X,\n            \n            \n              Chen\n              J,\n            \n            \n              Wang\n              J,\n            \n            et al.\n          \n          Overview of the 2022 WHO Classification of Pituitary Adenomas\/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives.\nCurr Med Sci.\n2022;\n42:\n1111\u20131118.\nhttps:\/\/doi.org\/10.1007\/s11596-022-2673-6"},{"key":"i0743-6661-50-2-154-ref06","series-title":"Transl Cancer Res","first-page":"1916","article-title":"Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective","volume":"10","author":"Liu","year":"2021","unstructured":"Liu\n              X,\n            \n            \n              Wang\n              R,\n            \n            \n              Li\n              M,\n            \n            \n              Chen\n              G.\n            \n          \n          Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective.\nTransl Cancer Res.\n2021;\n10:\n1916-\n1920.\ndoi: 10.21037\/tcr-20-3446.\nPMID: 35116513; PMCID: PMC8798339"},{"key":"i0743-6661-50-2-154-ref07","series-title":"JAMA","first-page":"1386","article-title":"Diagnosis and Management of Pituitary Adenomas: A Review","volume":"329","author":"Tritos","year":"2023","unstructured":"Tritos\n              NA,\n            \n            \n              Miller\n              KK.\n            \n          \n          Diagnosis and Management of Pituitary Adenomas: A Review.\nJAMA.\n2023;\n329:\n1386-\n1398.\ndoi:10.1001\/jama.2023.5444"},{"key":"i0743-6661-50-2-154-ref08","unstructured":"ICD-11 for Mortality and Morbidity Statistics (version 01, 2023)\n          \n            https:\/\/icd.who.int\/browse11\/l-m\/en","article-title":"ICD-11 for Mortality and Morbidity Statistics (version 01, 2023)"},{"year":"(2013)","series-title":"International Classification of Diseases for Oncology","key":"i0743-6661-50-2-154-ref09","unstructured":"International Classification of Diseases for Oncology.\nThird Edition, First revision\n(2013)https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/96612\/9789241548496_eng.pdf"},{"key":"i0743-6661-50-2-154-ref10","series-title":"WHO Classification of Tumours Editorial Board. Central Nervous System Tumours","article-title":"Tumours of the Sellar Region","volume":"6","author":"Brat","year":"2021","unstructured":"Brat\n              D,\n            \n            \n              Gill\n              A,\n            \n            \n              Wesseling\n              P,\n            \n            et al.\n          \n          Tumours of the Sellar Region. In:\nWHO Classification of Tumours Editorial Board. Central Nervous System Tumours.\n5th ed.; vol.\n6 [Internet].\nLyon (France):\nInternational Agency for Research on Cancer;\n2021.\nAvailable from: https:\/\/tumourclassification.iarc.who.int\/chapters\/45."},{"key":"i0743-6661-50-2-154-ref11","series-title":"WHO Classification of Tumours Editorial Board. Endocrine And Neuroendocrine Tumours","article-title":"Pituitary Tumours","volume":"10 [Internet]","author":"Asa","year":"2022","unstructured":"Asa\n              S,\n            \n            \n              Osamura\n              R,\n            \n            \n              Mete\n              O.\n            \n          \n          Pituitary Tumours. In:\nWHO Classification of Tumours Editorial Board. Endocrine And Neuroendocrine Tumours.\n5th ed.; vol.\n10 [Internet].\nLyon (France):\nInternational Agency for Research on Cancer;\n2022.\nAvailable from: https:\/\/tumourclassification.iarc.who.int\/chapters\/53."},{"key":"i0743-6661-50-2-154-ref12","unstructured":"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/tumor"}],"container-title":["Journal of Insurance Medicine"],"original-title":[],"link":[{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/50\/2\/article-p154.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/jim\/article-pdf\/50\/2\/154\/3330474\/i0743-6661-50-2-154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/50\/2\/article-p154.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/50\/2\/article-p154.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:39:41Z","timestamp":1747355981000},"score":1,"resource":{"primary":{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/50\/2\/article-p154.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":12,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.17849\/insm-50-2-154-156.1","relation":{},"ISSN":["0743-6661"],"issn-type":[{"type":"print","value":"0743-6661"}],"subject":[],"published":{"date-parts":[[2023]]}}}